BRPI0821105A2 - ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular - Google Patents

ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular

Info

Publication number
BRPI0821105A2
BRPI0821105A2 BRPI0821105A BRPI0821105A BRPI0821105A2 BR PI0821105 A2 BRPI0821105 A2 BR PI0821105A2 BR PI0821105 A BRPI0821105 A BR PI0821105A BR PI0821105 A BRPI0821105 A BR PI0821105A BR PI0821105 A2 BRPI0821105 A2 BR PI0821105A2
Authority
BR
Brazil
Prior art keywords
diseases
therapeutic
diagnostic tools
vascular function
alter vascular
Prior art date
Application number
BRPI0821105A
Other languages
English (en)
Inventor
Erik Sjoerd Gerard Stroes
Hans Vink
Original Assignee
Academisch Ziekenhuis Maastricht
Univ Maastricht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academisch Ziekenhuis Maastricht, Univ Maastricht filed Critical Academisch Ziekenhuis Maastricht
Publication of BRPI0821105A2 publication Critical patent/BRPI0821105A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/525Tumor necrosis factor [TNF]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50Lipopolysaccharides; LPS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/323Arteriosclerosis, Stenosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/328Vasculitis, i.e. inflammation of blood vessels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0821105A 2007-11-30 2008-12-01 ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular BRPI0821105A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07122043 2007-11-30
PCT/EP2008/066524 WO2009068685A1 (en) 2007-11-30 2008-12-01 Diagnostic and therapeutic tools for diseases altering vascular function

Publications (1)

Publication Number Publication Date
BRPI0821105A2 true BRPI0821105A2 (pt) 2015-10-06

Family

ID=39247715

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821105A BRPI0821105A2 (pt) 2007-11-30 2008-12-01 ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular

Country Status (12)

Country Link
US (1) US8759095B2 (pt)
EP (1) EP2215480B1 (pt)
JP (1) JP5597543B2 (pt)
CN (1) CN101918845B (pt)
AT (1) ATE554396T1 (pt)
BR (1) BRPI0821105A2 (pt)
CA (1) CA2706307C (pt)
DK (1) DK2215480T3 (pt)
ES (1) ES2386231T3 (pt)
PL (1) PL2215480T3 (pt)
PT (1) PT2215480E (pt)
WO (1) WO2009068685A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2215480B1 (en) 2007-11-30 2012-04-18 Universiteit Maastricht Diagnostic and therapeutic tools for diseases altering vascular function
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
US10070796B2 (en) 2015-02-04 2018-09-11 General Electric Company Systems and methods for quantitative microcirculation state monitoring
KR101972691B1 (ko) 2015-04-08 2019-04-25 마이크로바스쿨라 헬스 솔루션즈, 엘엘씨 상승적인 글리코칼릭스 치료 조성물 및 방법
CA3022351A1 (en) 2015-04-29 2016-11-03 Kardiatonos, Inc. Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage
US10507253B2 (en) 2016-03-17 2019-12-17 Paul C. Lee Nanoparticle probes and methods of making and use thereof
US10507252B2 (en) 2016-03-17 2019-12-17 Paul C. Lee Nanoparticle probes and methods of making and use thereof
WO2018208846A1 (en) * 2017-05-08 2018-11-15 Microvascular Health Solutions, LLC Compositions, systems, and methods for assessing and improving vascular health and treatments involving the same
CN107271348B (zh) * 2017-07-06 2019-11-15 苏州大学 一种医用人造管道渗透性能测试系统及其使用方法
WO2019115724A1 (en) * 2017-12-13 2019-06-20 Valle Brian William Della Biomarkers for multiple sclerosis
CN108681510A (zh) * 2018-05-21 2018-10-19 迈克医疗电子有限公司 数据处理方法及装置
EP3623816A1 (en) 2018-09-12 2020-03-18 GLX Analytix ApS Glx-derived molecule detection
US11319519B2 (en) * 2018-12-12 2022-05-03 Macau Glcao Biotechnology Research Center Limited Method and apparatus for screening compounds that have preventative and therapeutic activities against endothelial glycocalyx-related diseases
US11852577B2 (en) * 2021-09-29 2023-12-26 Orange Biomed Ltd., Co. Apparatus for measuring properties of particles in a solution and related methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
JP3566756B2 (ja) 1993-09-03 2004-09-15 謙 石原 非侵襲血液分析装置とその方法
JP2003510112A (ja) * 1999-09-23 2003-03-18 ジー.ナドウ リチャード 直交偏光スペクトルイメージングの医学的応用
ES2321082T3 (es) * 2002-05-09 2009-06-02 Hemoteq Ag Productos medicos que comprenden un revestimiento hemocompatible, produccion y uso de los mismos.
EP1661516B1 (en) * 2003-09-02 2012-08-15 Koji Sode Glucose sensor and glucose level measuring apparatus
JP2007536974A (ja) 2004-05-14 2007-12-20 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 光ファイバプローブ
JP2007054483A (ja) 2005-08-26 2007-03-08 Olympus Corp 装着型顕微鏡システム
WO2007075388A2 (en) * 2005-12-15 2007-07-05 X-Cell Medical Incorporated Methods of locally treating and preventing cardiac disorders
EP2215480B1 (en) 2007-11-30 2012-04-18 Universiteit Maastricht Diagnostic and therapeutic tools for diseases altering vascular function

Also Published As

Publication number Publication date
CA2706307A1 (en) 2009-06-04
PT2215480E (pt) 2012-07-18
CN101918845B (zh) 2014-01-29
ATE554396T1 (de) 2012-05-15
US8759095B2 (en) 2014-06-24
EP2215480A1 (en) 2010-08-11
JP2011507560A (ja) 2011-03-10
JP5597543B2 (ja) 2014-10-01
US20100304424A1 (en) 2010-12-02
ES2386231T3 (es) 2012-08-14
CN101918845A (zh) 2010-12-15
CA2706307C (en) 2017-01-17
WO2009068685A1 (en) 2009-06-04
EP2215480B1 (en) 2012-04-18
PL2215480T3 (pl) 2012-09-28
DK2215480T3 (da) 2012-07-30

Similar Documents

Publication Publication Date Title
BRPI0821105A2 (pt) ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular
CY1123217T1 (el) Παγιδες gdf
CY1112912T1 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
ECSP10010344A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
BRPI0815564A2 (pt) Anticorpos que inibem a dimerização de c-met e usos dos mesmos.
CO6450665A2 (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
PA8774501A1 (es) Nueva sales y sus usos
UY31563A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
MA32934B1 (fr) Combinaisons inhibitrices hsp90
ECSP10010580A (es) Inmunoglobulinas duales de dominio variable y sus aplicaciones
EA201101520A1 (ru) Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
BRPI0806941A2 (pt) Implementos de higiene bucal que têm elementos flexíveis, e métodos de produção dos mesmos
ATE476655T1 (de) Doxorubicin-immuntest
ES2352576T8 (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana.
GT200800123A (es) Compuestos mimeticos de lisina modificados
ECSP11011496A (es) Inmunoglobulinas de dominio variable dual y usos de las mismas
BRPI1008692A2 (pt) moléculas de anticorpos tendo especificidade para ox40 humano.
BRPI0923507A2 (pt) motor e dispositivo elétrico que usa o mesmo.
SV2009003392A (es) Aril pirrolidinas insecticidas
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
BRPI1010887A2 (pt) derivados de triazina e suas aplicações terapêuticas.
BRPI0719904A2 (pt) Aço inoxidável martensítico
MA32349B1 (fr) Antagonistes de la voie hedgehog a base de phtalazines disubstituees
BR112012014669A2 (pt) componente para artigo de fumar, artigo de fumar e método
BR112014008224A2 (pt) derivados do fator vii e viia de coagulação sanguínea, conjugados e complexos que incluem o mesmo e utilização do mesmo

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL